These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12131334)

  • 21. Transdermal oxybutynin. A viewpoint by Michael Chancellor.
    Chancellor M
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964893
    [No Abstract]   [Full Text] [Related]  

  • 22. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.
    Holmes DM; Montz FJ; Stanton SL
    Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravesical irrigation with an aluminum solution in intractable bladder hemorrhage].
    Torrecilla C; Aguiló F; Muñoz J; De la Peña MD; Serrallach N
    Actas Urol Esp; 1987; 11(5):457-60. PubMed ID: 3453585
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.
    Enzelsberger H; Helmer H; Kurz C
    Br J Obstet Gynaecol; 1995 Nov; 102(11):929-30. PubMed ID: 8534633
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bladder dysfunction in children].
    Bensman A; Deschenes G; Audry G; Grapin C
    Ann Urol (Paris); 1995; 29(5):302-5. PubMed ID: 8638913
    [No Abstract]   [Full Text] [Related]  

  • 26. Oxybutynin administration diminishes the high gastric muscular tone associated with bladder reconstruction.
    Sheldon CA; Reeves D; Lewis AG
    J Urol; 1995 Feb; 153(2):461-2. PubMed ID: 7815620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxybutynin chloride in control of post-trasurethral vesical pain and spasm.
    Paulson DF
    Urology; 1978 Mar; 11(3):237-8. PubMed ID: 345586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical experimentation with injectable Parapenzolate in urology].
    Schilliro R; Coste
    J Urol Nephrol (Paris); 1972; 78(10):950-2. PubMed ID: 4659954
    [No Abstract]   [Full Text] [Related]  

  • 30. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R; Luque R
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of hyperhidrosis with oxybutynin.
    Schollhammer M; Misery L
    Arch Dermatol; 2007 Apr; 143(4):544-5. PubMed ID: 17438194
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adverse effects of oxybutynin chloride (Ditropan) in pediatrics].
    Jonville AP; Dutertre JP; Barbellion M; Autret E
    Arch Fr Pediatr; 1993 Jan; 50(1):27-9. PubMed ID: 8507135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical effect of intravesical oxybutynin.
    Bonney WW; Robinson RA; Theobald RJ
    J Urol; 1993 Nov; 150(5 Pt 1):1522-5. PubMed ID: 8411446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical diamorphine for bladder spasm.
    McCoubrie R; Jeffrey D
    J Pain Symptom Manage; 2003 Jan; 25(1):1-3. PubMed ID: 12565179
    [No Abstract]   [Full Text] [Related]  

  • 35. Lidocaine toxicity secondary to postoperative bladder instillation in a pediatric patient.
    Clapp CR; Poss WB; Cilento BG
    Urology; 1999 Jun; 53(6):1228. PubMed ID: 10754119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relief of bladder spasm by flavoxate. A comparative study.
    Bradley DV; Cazort RJ
    J Clin Pharmacol J New Drugs; 1970; 10(1):65-8. PubMed ID: 4903954
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of Lioresal in spasticity].
    Castaigne P; Held JP; Laplane D; Pierrot-Deseilligny E; Bussel B; Macquart-Moulin J
    Rev Neurol (Paris); 1973 Apr; 128(4):245-50. PubMed ID: 4774911
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxybutynin dependence: a case presentation.
    Mutlu EA
    Turk Psikiyatri Derg; 2011; 22(2):131-2. PubMed ID: 21780343
    [No Abstract]   [Full Text] [Related]  

  • 39. [The medical treatment of overactive bladder].
    Beneton C; De Parisot O
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):369-76. PubMed ID: 12746713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
    De Wachter S; Wyndaele JJ
    J Urol; 2003 May; 169(5):1892-5. PubMed ID: 12686868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.